News Details
NCCN Annual Congress on Hematologic Malignancies In-Person for First Time in Three Years; Virtual Attendance Also Available
The NCCN 2022 Annual Congress: Hematologic Malignancies™ (#NCCNhem22) utilizes continuing education to advance patient outcomes by improving the understanding and performance of health care providers treating people with blood cancers.
The hybrid event will take place in New York City and sessions will be livestreamed virtually Friday, October 14, 2022 – Saturday, October 15, 2022.
The NCCN 2022 Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™ will also be held in New York City and sessions will be livestreamed virtually October 15, 2022, immediately following the NCCN 2022 Annual Congress: Hematologic Malignancies.
What:
NCCN’s annual gathering providing knowledge and insights from world-renowned experts for determining the optimal evidence-based treatment options for various blood cancers, and how best to protect vulnerable populations in a changing healthcare landscape. Live sessions will take place in-person and remotely through the virtual event platform so all attendees can access interactive presentations, debates, and case study discussions.
Featured topics include:
- Re-Vaccination After Cellular Therapy
- Transplant vs. CAR T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Incorporating Immunotherapies into Multiple Myeloma Management
- Familial/Genetic Leukemia Syndromes (online only)
- Hematopoietic Growth Factors (online only)
Plus the latest treatment recommendations for:
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- CLL/SLL
- Chronic Myeloid Leukemia
- Diffuse Large B-Cell Lymphoma
- Hodgkin Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Myelodysplastic Syndrome
- Myeloproliferative Neoplasms
- Systemic Amyloidosis
- Systemic Mastocytosis
When:
October 14-15 NCCN 2022 Congress: Hematologic Malignancies™
October 15 NCCN 2022 Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™
Who:
The planning committee was led by Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center, and includes Gabriela S. Hobbs, MD, Massachusetts General Hospital Cancer Center, Shaji K. Kumar, MD, Mayo Clinic Cancer Center, Bernard Marini, PharmD, BCOP, University of Michigan Rogel Cancer Center, and Brenda K. Shelton, DNP, RN, CCRN, AOCN, NPD-BC, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
The full faculty list includes 25 hematologic malignancy experts from across NCCN Member Institutions.
Visit NCCN.org/hem for the full agenda including all topics, faculty, and learning objectives.
Visit NCCN.org/nursing for more information on the 2022 Nursing Forum, including agenda topics and speakers.
NCCN is committed to maintaining the health and safety of all in-person attendees, guests, and staff. All in-person attendees are required to provide proof of COVID-19 vaccination. View Health & Safety Information here.
Media can contact Rachel Darwin at darwin@nccn.org for complimentary press registration.
Join the conversation online with the hashtag #NCCNhem22.
# # #
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information and follow NCCN on Facebook @NCCNorg, Instagram @NCCNorg and Twitter @NCCN.